Foghorn Therapeutics Inc. FHTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
5.51UNCH (UNCH)
Volume
3,585,564
Close
5.51quote price arrow down-0.30 (-5.16%)
Volume
60,661
52 week range
2.70 - 9.97
Loading...
  • Open5.86
  • Day High6.02
  • Day Low5.47
  • Prev Close5.81
  • 52 Week High9.97
  • 52 Week High Date08/15/23
  • 52 Week Low2.70
  • 52 Week Low Date02/05/24

Key Stats

  • Market Cap234.647M
  • Shares Out42.59M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta3.12
  • YTD % Change-9.92

KEY STATS

  • Open5.86
  • Day High6.02
  • Day Low5.47
  • Prev Close5.81
  • 52 Week High9.97
  • 52 Week High Date08/15/23
  • 52 Week Low2.70
  • 52 Week Low Date02/05/24
  • Market Cap234.647M
  • Shares Out42.59M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta3.12
  • YTD % Change-9.92

RATIOS/PROFITABILITY

  • EPS (TTM)-2.21
  • P/E (TTM)-2.50
  • Fwd P/E (NTM)-2.45
  • EBITDA (TTM)-99.308M
  • ROE (TTM)-470.38%
  • Revenue (TTM)33.896M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-274.23%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Foghorn Therapeutics Inc.

 

Profile

MORE
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company engaged in developing medicines that modulate gene expression through selectively targeting the chromatin regulatory system for therapeutic intervention in oncology. Its Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing to identify, validate and potentially drug targets within the system. The...
Adrian Gottschalk
President, Chief Executive Officer, Director
Kristian Humer
Chief Financial Officer
Address
500 Technology Square, Suite 700
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
ZVRA
Zevra Therapeutics Inc
4.73-0.03-0.63%
MGNX
MacroGenics Inc
4.37-0.75-14.75%
CRBU
Caribou Biosciences Inc
3.39-0.20-5.57%
BLUE
bluebird bio Inc
1.03-0.02-1.90%
ACIU
AC Immune SA
3.18-0.23-6.74%